Skip to main content

Advertisement

Springer Nature Link
Log in

Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion

  • Case Report
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

Central nervous system (CNS) ganglioneuroblastoma is a rare neuroectodermal neoplasm and little is known about its clinical and biological features. Herein, we report a pediatric case of CNS ganglioneuroblastoma harboring MYO5A-NTRK3 fusion. The patient, a 4-year-old boy, underwent a partial resection of a supratentorial tumor that was histopathologically diagnosed as a CNS ganglioneuroblastoma. Treatment with radiotherapy was started per the St Jude Medulloblastoma 03 (SJMB03) protocol; however, the tumor progressed rapidly and radiotherapy was temporally discontinued. Meanwhile, the patient underwent a second surgery, in which a gross total resection was successfully performed, following which he completed the remaining protocol-based therapy. Although an early focal recurrence was detected for which he received additional radiotherapy and oral temozolomide, the patient remained in complete remission for 14 months after the completion of the treatment. A central pathological review and molecular analysis were performed that revealed a MYO5A-NTRK3 fusion. Interestingly, the MYO5A-NTRK3 fusion has been recurrently detected in melanocytic tumors but not in other types of tumors. Therefore, it can be speculated that our case might partly share tumorigenesis mechanisms with MYO5A-NTRK3-positive melanocytic tumors. In addition, our case may enable an improved understanding of the pathogenesis and clinical features of CNS ganglioneuroblastomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2016) WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyon

    Google Scholar 

  2. Lonergan GJ, Schwab CM, Suarez ES et al (2002) Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 22:911–934

    Article  Google Scholar 

  3. Mirza FA, Snyder B, Smith VD et al (2018) Pediatric supratentorial ganglioneuroblastoma: case report and review of literature. World Neurosurg 113:261–266

    Article  Google Scholar 

  4. Steenberge SP, Prayson RA (2014) Pediatric cerebral ganglioneuroblastoma. J Clin Neurosci 21:2023–2025

    Article  Google Scholar 

  5. Gasparetto EL, Rosemberg S, Matushita H et al (2007) Ganglioneuroblastoma of the cerebellum: neuroimaging and pathological features of a case. Arq Neuropsiquiatr 65:338–340

    Article  Google Scholar 

  6. Yao PS, Chen GR, Shang-Guan HC et al (2017) Adult hippocampal ganglioneuroblastoma: case report and literature review. Medicine (Baltimore) 96:e8894

    Article  Google Scholar 

  7. Mrowczynski OD, Lane JR, Specht CS et al (2020) Suprasellar central nervous system ganglioneuroblastoma: a case in a 9-year-old child and review of the literature. Childs Nerv Syst. https://doi.org/10.1007/s00381-020-04597-4

    Article  PubMed  Google Scholar 

  8. Liu APY, Gudenas B, Lin T et al (2019) Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol 139:259–271

    Article  CAS  Google Scholar 

  9. Padovani L, Andre N, Gentet JC et al (2011) Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease? J Pediatr Hematol Oncol 33:600–604

    Article  Google Scholar 

  10. Cefalo G, Massimino M, Ruggiero A et al (2014) Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial. Neuro Oncol 16:748–753

    Article  CAS  Google Scholar 

  11. Nakano Y, Tomiyama A, Kohno T et al (2019) Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma. Brain Tumor Pathol 36:14–19

    Article  CAS  Google Scholar 

  12. Nakano Y, Yamasaki K, Sakamoto H et al (2019) A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations. Brain Tumor Pathol 36:162–168

    Article  CAS  Google Scholar 

  13. Isales MC, Mohan LS, Quan VL et al (2019) Distinct genomic patterns in pigmented epithelioid melanocytoma: A molecular and histologic analysis of 16 Cases. Am J Surg Pathol 43:480–488

    Article  Google Scholar 

  14. VandenBoom T, Quan VL, Zhang B et al (2018) Genomic fusions in pigmented spindle cell nevus of Reed. Am J Surg Pathol 42:1042–1051

    Article  Google Scholar 

  15. Wang L, Busam KJ, Benayed R et al (2017) Identification of NTRK3 fusions in childhood melanocytic neoplasms. J Mol Diagn 19:387–396

    Article  CAS  Google Scholar 

  16. Yeh I, Tee MK, Botton T et al (2016) NTRK3 kinase fusions in Spitz tumours. J Pathol 240:282–290

    Article  CAS  Google Scholar 

  17. Fujimoto M, Togashi Y, Matsuzaki I et al (2018) A case report of atypical Spitz tumor harboring a novel MLPH-ALK gene fusion with discordant ALK immunohistochemistry results. Hum Pathol 80:99–103

    Article  CAS  Google Scholar 

  18. Chung CT, Marrano P, Swanson D et al (2019) Fusion of ALK to the melanophilin gene MLPH in pediatric Spitz nevi. Hum Pathol 87:57–64

    Article  CAS  Google Scholar 

  19. Nagashima Y, Miyagi Y, Tanaka Y et al (1997) Adult ganglioneuroblastoma of the anterior mediastinum. Pathol Res Pract 193:727–732 (discussion 733)

    Article  CAS  Google Scholar 

  20. Banerjee SS, Menasce LP, Eyden BP et al (1999) Malignant melanoma showing ganglioneuroblastic differentiation: report of a unique case. Am J Surg Pathol 23:582–588

    Article  CAS  Google Scholar 

  21. Castelli E, Orlando E, Pistone G et al (2018) Plexiform atypical Spitz tumor with Rosette-like giant cells: a histologic and immunohistochemical study on a case suggesting ganglioneuroblastic differentiation: review of the literature and considerations on histogenesis. Am J Dermatopathol 40:903–907

    Article  Google Scholar 

  22. Maguire LH, Thomas AR, Goldstein AM (2015) Tumors of the neural crest: common themes in development and cancer. Dev Dyn 244:311–322

    Article  Google Scholar 

  23. Dupin E, Calloni GW, Coelho-Aguiar JM et al (2018) The issue of the multipotency of the neural crest cells. Dev Biol 444:S47–S59

    Article  CAS  Google Scholar 

  24. Cichorek M, Wachulska M, Stasiewicz A et al (2013) Skin melanocytes: biology and development. Postepy Dermatol Alergol 30:30–41

    Article  Google Scholar 

  25. Laetsch TW, DuBois SG, Mascarenhas L et al (2018) Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. Lancet Oncol 19:705–714

    Article  CAS  Google Scholar 

  26. Robinson GW, Gajjar AJ, Gauvain KM et al (2019) Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors. J Clin Oncol 37:10009–10009

    Article  Google Scholar 

  27. Drilon AE, DuBois SG, Farago AF et al (2019) Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors. J Clin Oncol 37:2006–2006

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the patient and his family for participating in this research. We also thank Takako Yoshioka for her support in diagnosis and M. Honda-Kitahara and Yuko Hibiya for their technical assistance. This work was supported in part by the Japan Children’s Cancer Group (JCCG) and by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (Grant Number JP20K16873).

Author information

Authors and Affiliations

  1. Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan

    Jumpei Ito, Haruko Shima, Kyohei Isshiki, Fumito Yamazaki & Hiroyuki Shimada

  2. Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan

    Yoshiko Nakano & Koichi Ichimura

  3. Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan

    Tomoru Miwa, Yumiko Oishi & Yukina Morimoto

  4. Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan

    Yasunori Kogure & Keisuke Kataoka

  5. Division of Diagnostic Pathology, Keio University School of Medicine, Tokyo, Japan

    Hajime Okita

  6. Department of Pathology, Gunma University Hospital, Maebashi, Japan

    Junko Hirato

Authors
  1. Jumpei Ito
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Yoshiko Nakano
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Haruko Shima
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Tomoru Miwa
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Yasunori Kogure
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Kyohei Isshiki
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Fumito Yamazaki
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Yumiko Oishi
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Yukina Morimoto
    View author publications

    You can also search for this author inPubMed Google Scholar

  10. Keisuke Kataoka
    View author publications

    You can also search for this author inPubMed Google Scholar

  11. Hajime Okita
    View author publications

    You can also search for this author inPubMed Google Scholar

  12. Junko Hirato
    View author publications

    You can also search for this author inPubMed Google Scholar

  13. Koichi Ichimura
    View author publications

    You can also search for this author inPubMed Google Scholar

  14. Hiroyuki Shimada
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Yoshiko Nakano.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest associated with this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 28 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ito, J., Nakano, Y., Shima, H. et al. Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion. Brain Tumor Pathol 37, 105–110 (2020). https://doi.org/10.1007/s10014-020-00371-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-020-00371-1

Keywords